Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
Sponsor: Eli Lilly and Company
Summary
The main purpose of this study is to measure the safety and efficacy of tirzepatide in adult participants in India who have type 2 diabetes or who have obesity or overweight without type 2 diabetes. Participation in the study will last about 46 weeks.
Official title: A Phase 4, Open-Label, Single-Arm, 46-Week Study to Investigate the Safety and Efficacy With Tirzepatide in Adult Indian Participants With Either Type 2 Diabetes or Obesity
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
344
Start Date
2026-03
Completion Date
2027-10
Last Updated
2026-02-27
Healthy Volunteers
No
Interventions
Tirzepatide
Administered SC
Locations (21)
B. J. Medical College & Civil Hospital
Ahmedabad, India
V.S. General Hospital
Ahmedabad, India
Gujarat Endocrine Center
Ahmedabad, India
Jawahar Lal Nehru Medical College
Ajmer, India
Motilal Nehru Medical College Hospital
Allahabād, India
Lifecare Hospital and Research Centre
Bengaluru, India
AIIMS, Bhubaneshwar
Bhubaneswar, India
Sri Ramachandra MedicaL College & Research Institute
Chennai, India
Kovai Diabetes Speciality Center and Hospital
Coimbatore, India
Apollo Excelcare Hospital
Guwahati, India
Osmania Medical College & Hospital
Hyderabad, India
Eternal Heart Care Center and Research Institute
Jaipur, India
K care Hospital
Kanpur, India
Brij Medical Centre Private Limited
Kanpur, India
ILS Hospitals
Kolkata, India
Government Medical College, Kozhikode
Kozhikode, India
Wockhardt Hospitals
Mumbai, India
Shri Krishna Hrudayalaya & Critical Care Centre
Nagpur, India
Sahyadri Super Speciality Hospital
Pune, India
All India Institute of Medical Sciences
Raipur, India
King George Hospital, Andhra Medical College
Visakhapatnam, India